Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation. / Sørensen, T I; Toftdahl, D B; Højgaard, L; Cantor, P; Klein, H C; Andersen, B.

In: Danish Medical Bulletin (Print), Vol. 41, No. 4, 09.1994, p. 469-72.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sørensen, TI, Toftdahl, DB, Højgaard, L, Cantor, P, Klein, HC & Andersen, B 1994, 'Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation', Danish Medical Bulletin (Print), vol. 41, no. 4, pp. 469-72.

APA

Sørensen, T. I., Toftdahl, D. B., Højgaard, L., Cantor, P., Klein, H. C., & Andersen, B. (1994). Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation. Danish Medical Bulletin (Print), 41(4), 469-72.

Vancouver

Sørensen TI, Toftdahl DB, Højgaard L, Cantor P, Klein HC, Andersen B. Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation. Danish Medical Bulletin (Print). 1994 Sep;41(4):469-72.

Author

Sørensen, T I ; Toftdahl, D B ; Højgaard, L ; Cantor, P ; Klein, H C ; Andersen, B. / Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation. In: Danish Medical Bulletin (Print). 1994 ; Vol. 41, No. 4. pp. 469-72.

Bibtex

@article{070fe2547ec24b15818da09b2465053c,
title = "Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation",
abstract = "BACKGROUND AND AIM: Jejunoileal bypass surgery for obesity increases the risk of gallstone formation, and, contrary to expectations, the incidence is greater in patients with a long as compared to a short ileum left in continuity. Impaired gallbladder motility due to reduced cholecystokinin (CCK) stimulation could be an explanation. The aim of this study was to investigate the CCK levels in such patients.SETTING: The randomized trial of bypass surgery named The Danish Obesity Project.DESIGN AND METHODS: We compared plasma levels of CCK in obese patients at three, nine or 15 months after jejunoileal bypass surgery with either a 1:3 jejunoileal ratio (n = 14) or a 3:1 ratio (n = 15), and in unoperated obese patients (n = 7). Plasma CCK levels were determined during fasting and during 150 min following ingestion of a liquid test meal.RESULTS: There were no significant changes over time following surgery. Basal CCK levels were significantly increased after surgery, and significantly higher in those with a 3:1 than in those with a 1:3 jejunoileal ratio. The postprandial AUC (mean +/- SEM) was 935 +/- 71 pM x min in the 3:1 ratio group and 891 +/- 100 pM x min in the 1:3 ratio group. This difference was not significant, but both bypass groups were significantly higher than the unoperated group (515 +/- 79 pM x min). The integrated increase in plasma CCK above basal level showed a similar pattern, but the difference between the unoperated and the bypass groups was insignificant.CONCLUSION: Postoperative changes in plasma CCK levels neither explain the increased risk of gallstone formation after bypass surgery nor the higher incidence with a long compared to a short ileum left in continuity in the bypass.",
keywords = "Cholecystokinin, Cholelithiasis, Cross-Sectional Studies, Eating, Fasting, Food, Humans, Jejunoileal Bypass, Obesity, Morbid, Risk Factors, Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial",
author = "S{\o}rensen, {T I} and Toftdahl, {D B} and L H{\o}jgaard and P Cantor and Klein, {H C} and B Andersen",
year = "1994",
month = sep,
language = "English",
volume = "41",
pages = "469--72",
journal = "Danish Medical Bulletin",
issn = "0907-8916",
publisher = "Danish Medical Association and Danish Medical Society",
number = "4",

}

RIS

TY - JOUR

T1 - Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation

AU - Sørensen, T I

AU - Toftdahl, D B

AU - Højgaard, L

AU - Cantor, P

AU - Klein, H C

AU - Andersen, B

PY - 1994/9

Y1 - 1994/9

N2 - BACKGROUND AND AIM: Jejunoileal bypass surgery for obesity increases the risk of gallstone formation, and, contrary to expectations, the incidence is greater in patients with a long as compared to a short ileum left in continuity. Impaired gallbladder motility due to reduced cholecystokinin (CCK) stimulation could be an explanation. The aim of this study was to investigate the CCK levels in such patients.SETTING: The randomized trial of bypass surgery named The Danish Obesity Project.DESIGN AND METHODS: We compared plasma levels of CCK in obese patients at three, nine or 15 months after jejunoileal bypass surgery with either a 1:3 jejunoileal ratio (n = 14) or a 3:1 ratio (n = 15), and in unoperated obese patients (n = 7). Plasma CCK levels were determined during fasting and during 150 min following ingestion of a liquid test meal.RESULTS: There were no significant changes over time following surgery. Basal CCK levels were significantly increased after surgery, and significantly higher in those with a 3:1 than in those with a 1:3 jejunoileal ratio. The postprandial AUC (mean +/- SEM) was 935 +/- 71 pM x min in the 3:1 ratio group and 891 +/- 100 pM x min in the 1:3 ratio group. This difference was not significant, but both bypass groups were significantly higher than the unoperated group (515 +/- 79 pM x min). The integrated increase in plasma CCK above basal level showed a similar pattern, but the difference between the unoperated and the bypass groups was insignificant.CONCLUSION: Postoperative changes in plasma CCK levels neither explain the increased risk of gallstone formation after bypass surgery nor the higher incidence with a long compared to a short ileum left in continuity in the bypass.

AB - BACKGROUND AND AIM: Jejunoileal bypass surgery for obesity increases the risk of gallstone formation, and, contrary to expectations, the incidence is greater in patients with a long as compared to a short ileum left in continuity. Impaired gallbladder motility due to reduced cholecystokinin (CCK) stimulation could be an explanation. The aim of this study was to investigate the CCK levels in such patients.SETTING: The randomized trial of bypass surgery named The Danish Obesity Project.DESIGN AND METHODS: We compared plasma levels of CCK in obese patients at three, nine or 15 months after jejunoileal bypass surgery with either a 1:3 jejunoileal ratio (n = 14) or a 3:1 ratio (n = 15), and in unoperated obese patients (n = 7). Plasma CCK levels were determined during fasting and during 150 min following ingestion of a liquid test meal.RESULTS: There were no significant changes over time following surgery. Basal CCK levels were significantly increased after surgery, and significantly higher in those with a 3:1 than in those with a 1:3 jejunoileal ratio. The postprandial AUC (mean +/- SEM) was 935 +/- 71 pM x min in the 3:1 ratio group and 891 +/- 100 pM x min in the 1:3 ratio group. This difference was not significant, but both bypass groups were significantly higher than the unoperated group (515 +/- 79 pM x min). The integrated increase in plasma CCK above basal level showed a similar pattern, but the difference between the unoperated and the bypass groups was insignificant.CONCLUSION: Postoperative changes in plasma CCK levels neither explain the increased risk of gallstone formation after bypass surgery nor the higher incidence with a long compared to a short ileum left in continuity in the bypass.

KW - Cholecystokinin

KW - Cholelithiasis

KW - Cross-Sectional Studies

KW - Eating

KW - Fasting

KW - Food

KW - Humans

KW - Jejunoileal Bypass

KW - Obesity, Morbid

KW - Risk Factors

KW - Clinical Trial

KW - Comparative Study

KW - Journal Article

KW - Randomized Controlled Trial

M3 - Journal article

C2 - 7813254

VL - 41

SP - 469

EP - 472

JO - Danish Medical Bulletin

JF - Danish Medical Bulletin

SN - 0907-8916

IS - 4

ER -

ID: 165891219